Skip to content

The effect of preoperative night dexmedetomidine nasal spray on postoperative delirium in elderly patients undergoing hip replacement

The effect of preoperative night dexmedetomidine nasal spray on postoperative delirium in elderly patients undergoing hip replacement

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122404
Enrollment
Unknown
Registered
2026-04-13
Start date
2026-04-13
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative delirium

Interventions

Control group:At 20:00 the day before surgery, administer saline nasal spray, one spray in each nostril.
Research group:At 20:00 the day before surgery, administer dexmedetomidine nasal spray, one spray in each nostril.

Sponsors

The First Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients scheduled for their first total hip arthroplasty under general anesthesia; 2.Age >= 60 years; 3.BMI 18-28 kg/m^2; 4.Patients classified as ASA I-III by the American Society of Anesthesiologists; 5.Signed informed consent for anesthesia;

Exclusion criteria

Exclusion criteria: 1.Patients with preoperative cognitive impairment (assessed using the MMSE scale); 2.Those with a history of schizophrenia, Alzheimer's disease, Parkinson's disease, or dementia (as indicated in the recorded medical history); 3.Heart rate <=60 beats/min or other severe conduction disorders, liver dysfunction (Child-Pugh grade B or C), or kidney dysfunction (uremic stage or receiving preoperative dialysis); 4.Currently using dexmedetomidine, esketamine, or benzodiazepines; 5. Allergic to dexmedetomidine used in this study; 5.Allergic to dexmedetomidine used in this study; 6.Unable to communicate or understand the scales assessed by the investigator; 7.Refusal to sign the informed consent or inability to cooperate with the protocol;

Design outcomes

Primary

MeasureTime frame
Incidence of delirium on postoperative;

Secondary

MeasureTime frame
Sleep staging;Other perioperative indicators;Athens Insomnia Scale (AIS);Effective pressing times of the analgesic pump, number of rescue analgesia instances;Quality of Recovery-15;Postoperative resting and movement NRS scores;10-item Telephone Interview of Cognitive Status;Pittsburgh Sleep Quality Index (PSQI);

Countries

China

Contacts

Public ContactWen Chao

The First Affiliated Hospital of Dalian Medical University

doctwen@163.com+86 18098876177

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 23, 2026